New data for DecisionDx-Melanoma

(1:33)

The DecisionDx®-Melanoma Test Complements Current Melanoma Staging

(1:8)

How DecisionDx-Melanoma Personalizes Skin Cancer Care: Dr. Shannon Trotter Explains

(2:3)

What is DecisionDx-Melanoma?

(1:59)

How DecisionDx-Melanoma Predicts Tumor Behavior: How a Dermatologist Explains the Test to Patients

(1:6)

How DecisionDx-Melanoma works and data supporting it

(1:46)

Uveal Melanoma Animated Video Castle Bioscience DecisionDx-UM

(4:58)

From fear to confidence: DecisionDx-Melanoma. Greg’s story of empowerment over a melanoma diagnosis

(4:5)

Overcoming vemurafenib resistance in melanoma cell lines

(4:52)

DecisionDx®-Melanoma Provides the Future of Melanoma Prognosis for Patient, Today

(4:46)

Getting answers for the many questions of melanoma with DecisionDx-Melanoma

(4:2)

How DecisionDx-Melanoma Enhances Patient Management: Insights from Dr. Neil Fernandez

(1:27)

How DecisionDx-Melanoma Goes Beyond Traditional Staging: Dr. Mark Gimbel Explains

(51)

How DecisionDx-Melanoma Supports Sentinel Biopsy Decisions: Insights from Dr. Shannon Trotter

(45)

How DecisionDx-Melanoma Identifies High-Risk Patients in Low-Risk Melanoma Cases

(1:45)

How the DecisionDx-Melanoma Test Helps You Make Informed Decisions About Your Melanoma Treatment

(2:44)

How DecisionDx-Melanoma Guides Pre- and Post-Operative Care: Insights from Surgical Oncologist

(1:55)

How DecisionDx-Melanoma Guides Care for Sentinel Lymph Node Negative Patients

(1:56)

How DecisionDx-Melanoma Identifies High-Risk Patients Among Low-Risk Melanomas

(1:54)

How the DecisionDx-Melanoma Test Can Impact Your Melanoma Treatment Plan: Beyond a Regular Biopsy

(2:2)